世界のロタウイルス感染症治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Rotavirus Infection Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12680 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、ロタウイルス感染症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ロタウイルス感染症治療の種類別市場規模（経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ロタウイルス感染症治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline、Bharat Biotech、Curevac、Ology Bioservices、BioKangtai ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口薬、注射薬 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・ロタウイルス感染症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ロタウイルス感染症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ロタウイルス感染症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ロタウイルス感染症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ロタウイルス感染症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Rotavirus Infection Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Rotavirus Infection Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Rotavirus Infection Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Rotavirus Infection Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Oral Drug
Injiectable Drug

Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by players, this report covers
GlaxoSmithKline
Bharat Biotech
Curevac
Ology Bioservices
BioKangtai

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Rotavirus Infection Therapeutics
1.2 Classification of Rotavirus Infection Therapeutics by Type
1.2.1 Overview: Global Rotavirus Infection Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Rotavirus Infection Therapeutics Revenue Market Share by Type in 2020
1.2.3 Oral Drug
1.2.4 Injiectable Drug
1.3 Global Rotavirus Infection Therapeutics Market by Application
1.3.1 Overview: Global Rotavirus Infection Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Rotavirus Infection Therapeutics Market Size & Forecast
1.5 Global Rotavirus Infection Therapeutics Market Size and Forecast by Region
1.5.1 Global Rotavirus Infection Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Rotavirus Infection Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Rotavirus Infection Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Rotavirus Infection Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Rotavirus Infection Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Rotavirus Infection Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Rotavirus Infection Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Rotavirus Infection Therapeutics Market Drivers
1.6.2 Rotavirus Infection Therapeutics Market Restraints
1.6.3 Rotavirus Infection Therapeutics Trends Analysis
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Rotavirus Infection Therapeutics Product and Solutions
2.1.4 GlaxoSmithKline Rotavirus Infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GlaxoSmithKline Recent Developments and Future Plans
2.2 Bharat Biotech
2.2.1 Bharat Biotech Details
2.2.2 Bharat Biotech Major Business
2.2.3 Bharat Biotech Rotavirus Infection Therapeutics Product and Solutions
2.2.4 Bharat Biotech Rotavirus Infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bharat Biotech Recent Developments and Future Plans
2.3 Curevac
2.3.1 Curevac Details
2.3.2 Curevac Major Business
2.3.3 Curevac Rotavirus Infection Therapeutics Product and Solutions
2.3.4 Curevac Rotavirus Infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Curevac Recent Developments and Future Plans
2.4 Ology Bioservices
2.4.1 Ology Bioservices Details
2.4.2 Ology Bioservices Major Business
2.4.3 Ology Bioservices Rotavirus Infection Therapeutics Product and Solutions
2.4.4 Ology Bioservices Rotavirus Infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Ology Bioservices Recent Developments and Future Plans
2.5 BioKangtai
2.5.1 BioKangtai Details
2.5.2 BioKangtai Major Business
2.5.3 BioKangtai Rotavirus Infection Therapeutics Product and Solutions
2.5.4 BioKangtai Rotavirus Infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 BioKangtai Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Rotavirus Infection Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Rotavirus Infection Therapeutics Players Market Share
3.2.2 Top 10 Rotavirus Infection Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Rotavirus Infection Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Rotavirus Infection Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Rotavirus Infection Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Rotavirus Infection Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Rotavirus Infection Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Rotavirus Infection Therapeutics Revenue by Type (2016-2026)
6.2 North America Rotavirus Infection Therapeutics Revenue by Application (2016-2026)
6.3 North America Rotavirus Infection Therapeutics Market Size by Country
6.3.1 North America Rotavirus Infection Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Rotavirus Infection Therapeutics Revenue by Type (2016-2026)
7.2 Europe Rotavirus Infection Therapeutics Revenue by Application (2016-2026)
7.3 Europe Rotavirus Infection Therapeutics Market Size by Country
7.3.1 Europe Rotavirus Infection Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Rotavirus Infection Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Rotavirus Infection Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Rotavirus Infection Therapeutics Market Size by Region
8.3.1 Asia-Pacific Rotavirus Infection Therapeutics Revenue by Region (2016-2026)
8.3.2 China Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Rotavirus Infection Therapeutics Revenue by Type (2016-2026)
9.2 South America Rotavirus Infection Therapeutics Revenue by Application (2016-2026)
9.3 South America Rotavirus Infection Therapeutics Market Size by Country
9.3.1 South America Rotavirus Infection Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Rotavirus Infection Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Rotavirus Infection Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Rotavirus Infection Therapeutics Market Size by Country
10.3.1 Middle East & Africa Rotavirus Infection Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Rotavirus Infection Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Rotavirus Infection Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Rotavirus Infection Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Rotavirus Infection Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Rotavirus Infection Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Rotavirus Infection Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 7. GlaxoSmithKline Major Business
Table 8. GlaxoSmithKline Rotavirus Infection Therapeutics Product and Solutions
Table 9. GlaxoSmithKline Rotavirus Infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bharat Biotech Corporate Information, Head Office, and Major Competitors
Table 11. Bharat Biotech Major Business
Table 12. Bharat Biotech Rotavirus Infection Therapeutics Product and Solutions
Table 13. Bharat Biotech Rotavirus Infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Curevac Corporate Information, Head Office, and Major Competitors
Table 15. Curevac Major Business
Table 16. Curevac Rotavirus Infection Therapeutics Product and Solutions
Table 17. Curevac Rotavirus Infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Ology Bioservices Corporate Information, Head Office, and Major Competitors
Table 19. Ology Bioservices Major Business
Table 20. Ology Bioservices Rotavirus Infection Therapeutics Product and Solutions
Table 21. Ology Bioservices Rotavirus Infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. BioKangtai Corporate Information, Head Office, and Major Competitors
Table 23. BioKangtai Major Business
Table 24. BioKangtai Rotavirus Infection Therapeutics Product and Solutions
Table 25. BioKangtai Rotavirus Infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Rotavirus Infection Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 27. Global Rotavirus Infection Therapeutics Revenue Share by Players (2019-2021)
Table 28. Breakdown of Rotavirus Infection Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Rotavirus Infection Therapeutics Players Head Office, Products and Services Provided
Table 30. Rotavirus Infection Therapeutics Mergers & Acquisitions in the Past Five Years
Table 31. Rotavirus Infection Therapeutics New Entrants and Expansion Plans
Table 32. Global Rotavirus Infection Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 33. Global Rotavirus Infection Therapeutics Revenue Share by Type (2016-2021)
Table 34. Global Rotavirus Infection Therapeutics Revenue Forecast by Type (2021-2026)
Table 35. Global Rotavirus Infection Therapeutics Revenue by Application (2016-2021)
Table 36. Global Rotavirus Infection Therapeutics Revenue Forecast by Application (2021-2026)
Table 37. North America Rotavirus Infection Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Rotavirus Infection Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Rotavirus Infection Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Rotavirus Infection Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Rotavirus Infection Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Rotavirus Infection Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Rotavirus Infection Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Rotavirus Infection Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Rotavirus Infection Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Rotavirus Infection Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Rotavirus Infection Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Rotavirus Infection Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Rotavirus Infection Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Rotavirus Infection Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Rotavirus Infection Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Rotavirus Infection Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Rotavirus Infection Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Rotavirus Infection Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Rotavirus Infection Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Rotavirus Infection Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Rotavirus Infection Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Rotavirus Infection Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Rotavirus Infection Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Rotavirus Infection Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Rotavirus Infection Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Rotavirus Infection Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Rotavirus Infection Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Rotavirus Infection Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Rotavirus Infection Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Rotavirus Infection Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Rotavirus Infection Therapeutics Picture
Figure 2. Global Rotavirus Infection Therapeutics Revenue Market Share by Type in 2020
Figure 3. Oral Drug
Figure 4. Injiectable Drug
Figure 5. Rotavirus Infection Therapeutics Revenue Market Share by Application in 2020
Figure 6. Hospital Pharmacies Picture
Figure 7. Retail Pharmacies Picture
Figure 8. Online Pharmacies Picture
Figure 9. Global Rotavirus Infection Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Rotavirus Infection Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Rotavirus Infection Therapeutics Revenue Market Share by Region (2016-2026)
Figure 12. Global Rotavirus Infection Therapeutics Revenue Market Share by Region in 2020
Figure 13. North America Rotavirus Infection Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Rotavirus Infection Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Rotavirus Infection Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Rotavirus Infection Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Rotavirus Infection Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Rotavirus Infection Therapeutics Market Drivers
Figure 19. Rotavirus Infection Therapeutics Market Restraints
Figure 20. Rotavirus Infection Therapeutics Market Trends
Figure 21. GlaxoSmithKline Recent Developments and Future Plans
Figure 22. Bharat Biotech Recent Developments and Future Plans
Figure 23. Curevac Recent Developments and Future Plans
Figure 24. Ology Bioservices Recent Developments and Future Plans
Figure 25. BioKangtai Recent Developments and Future Plans
Figure 26. Global Rotavirus Infection Therapeutics Revenue Share by Players in 2020
Figure 27. Rotavirus Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 28. Global Top 3 Players Rotavirus Infection Therapeutics Revenue Market Share in 2020
Figure 29. Global Top 10 Players Rotavirus Infection Therapeutics Revenue Market Share in 2020
Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 31. Global Rotavirus Infection Therapeutics Revenue Share by Type in 2020
Figure 32. Global Rotavirus Infection Therapeutics Market Share Forecast by Type (2021-2026)
Figure 33. Global Rotavirus Infection Therapeutics Revenue Share by Application in 2020
Figure 34. Global Rotavirus Infection Therapeutics Market Share Forecast by Application (2021-2026)
Figure 35. North America Rotavirus Infection Therapeutics Sales Market Share by Type (2016-2026)
Figure 36. North America Rotavirus Infection Therapeutics Sales Market Share by Application (2016-2026)
Figure 37. North America Rotavirus Infection Therapeutics Revenue Market Share by Country (2016-2026)
Figure 38. United States Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Canada Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Mexico Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Europe Rotavirus Infection Therapeutics Sales Market Share by Type (2016-2026)
Figure 42. Europe Rotavirus Infection Therapeutics Sales Market Share by Application (2016-2026)
Figure 43. Europe Rotavirus Infection Therapeutics Revenue Market Share by Country (2016-2026)
Figure 44. Germany Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. France Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. United Kingdom Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Russia Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Italy Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Rotavirus Infection Therapeutics Sales Market Share by Type (2016-2026)
Figure 50. Asia-Pacific Rotavirus Infection Therapeutics Sales Market Share by Application (2016-2026)
Figure 51. Asia-Pacific Rotavirus Infection Therapeutics Revenue Market Share by Region (2016-2026)
Figure 52. China Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Japan Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. South Korea Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. India Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Southeast Asia Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Australia Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South America Rotavirus Infection Therapeutics Sales Market Share by Type (2016-2026)
Figure 59. South America Rotavirus Infection Therapeutics Sales Market Share by Application (2016-2026)
Figure 60. South America Rotavirus Infection Therapeutics Revenue Market Share by Country (2016-2026)
Figure 61. Brazil Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Argentina Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Middle East and Africa Rotavirus Infection Therapeutics Sales Market Share by Type (2016-2026)
Figure 64. Middle East and Africa Rotavirus Infection Therapeutics Sales Market Share by Application (2016-2026)
Figure 65. Middle East and Africa Rotavirus Infection Therapeutics Revenue Market Share by Country (2016-2026)
Figure 66. Turkey Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Saudi Arabia Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. UAE Rotavirus Infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Methodology
Figure 70. Research Process and Data Source

---